Model Drug as Pore Former for Controlled Release of Water-Soluble Metoprolol Succinate from Ethylcellulose-Coated Pellets Without Lag Phase: Opportunities and Challenges

详细信息    查看全文

• 作者：Yuli Wang ; Jingjing Dai ; Xinyi Chang ; Meiyan Yang ; Ruifang Shen…
• 关键词：coated pellets ; curing treatment ; lag phase ; metoprolol succinate ; pore former
• 刊名：AAPS PharmSciTech
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：16
• 期：1
• 页码：35-44
• 全文大小：1,128 KB
• 参考文献：1. Bodmeier R. Tableting of coated pellets. Eur J Pharm Biopharm. 1997;43:1-. CrossRef
  2. Appel LE, Beyerinck RA, Chidlaw MB, Curatolo WJ, Friesen DT, Smith KL, Thombre AG. Hydrogel-driven drug dosage form. In: US Patent 2011/0182947 A1; 2011.
  3. Lindstedt B, Ragnarsson G, Hj?rtstam J. Osmotic pumping as a release mechanism for membrane-coated drug formulations. Int J Pharm. 1989;56:261-. CrossRef
  4. Ragnarsson G, Sandberg A, Johansson MO, Lindstedt B, Sj?gren J. / In vitro release characteristics of a membrane-coated pellet formulation—influence of drug solubility and particle size. Int J Pharm. 1992;79:223-2. CrossRef
  5. Marucci M, Ragnarsson G, von Corswant C, Welinder A, Jarke A, Iselau F, / et al. Polymer leaching from film coating: effects on the coating transport properties. Int J Pharm. 2011;411:43-. CrossRef
  6. Haddish-Berhane N, Jeong SH, Haghighi K, Park K. Modeling film-coat non-uniformity in polymer coated pellets: a stochastic approach. Int J Pharm. 2006;323:64-1. CrossRef
  7. Ensslin S, Moll KP, Paulus K, Mader K. New insight into modified release pellets-Internal structure and drug release mechanism. J Control Release. 2008;128:149-6. CrossRef
  8. Kaunisto E, Marucci M, Borgguist P, Axelsson A. Mechanistic modeling of drug release from polymer-coated and swelling and dissolving polymer matrix systems. Int J Pharm. 2011;418:54-7. CrossRef
  9. Appel LE, Friesen DT, Herbig SM, Thombre AG. Controlled release dosage forms combining immediate release and sustained release of low-solubility drug. In: US Patent 2008/0299188 A1; 2008.
  10. Avramoff A, Domb AJ. / In- / vitro and / in- / vivo characteristics of a modified-release double-pulse formulation for a water soluble drug. Int J Clin Pharmacol Ther. 2010;48:250-. CrossRef
  11. Verma RK, Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur J Pharm Biopharm. 2004;57:513-5. CrossRef
  12. Kumaravelrajan R, Narayanan N, Suba V. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination. Lipids Health Dis. 2011;10:51-4. CrossRef
  13. Gunder W, Lippold BH, Lippold BC. Release of drugs from ethyl cellulose microcapsules (diffusion pellets) with pore formers and pore fusion. Eur J Pharm Sci. 1995;3:203-4. CrossRef
  14. Siepmann F, Hoffmann A, Leclercq B, Carlin B, Siepmann J. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release. 2007;119:182-. CrossRef
  15. Bodmeier R, Paeratakul O. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions. Pharm Res. 1991;8:355-. CrossRef
  16. Lin WJ, Shiue GR. Elucidation of two water leachable polymers impact on microporous membrane performance and drug permeation. J Memb Sci. 2011;373:189-5. CrossRef
  17. Tuntikulwattana S, Mitrevej A, Kerdcharoen T, Williams DB, Sinchaipanid N. Development and optimization of micro/nanoporous osmotic pump tablets. AAPS PharmSciTech. 2010;11:924-5. CrossRef
  18. Ki
• 刊物主题：Pharmacology/Toxicology; Biotechnology; Biochemistry, general; Pharmacy;
• 出版者：Springer US
• ISSN：1530-9932

文摘

The objective of the present study was to evaluate the feasibility of using model drug metoprolol succinate (MS) as a pore former to modify the initial lag phase (i.e., a slow or non-release phase in the first 1- h) associated with the drug release from coated pellets. MS-layered cores with high drug-layering efficiency (97% w/w) were first prepared by spraying a highly concentrated drug aqueous solution (60% w/w, 70°C) on non-pareils without using other binders. The presence of MS in ethylcellulose (EC) coating solution significantly improved the coating process by reducing pellets sticking, which often occurs during organic coating. There may be a maximum physical compatibility of MS with EC, and the physical state of the drug in the functional coating layer of EC/MS (80:20) was simultaneously crystalline and non-crystalline (amorphous or solid molecule solution). The lag phase associated with hydroxypropylcellulose (HPC) as a pore former was not observed when MS was used as a pore former. The drug release from EC/MS-coated pellets was pH independent, inversely proportional to the coating levels, and directly related to the pore former levels. The functional coating layer with MS as a pore former was not completely stabilized without curing. Curing at 60°C for 1 day could substantially improve the stability of EC/MS-coated pellets. The physical state of the drug in the free film of EC/MS (85:15) changed partially from amorphous to crystal when cured at 60°C for 1 day, which should be attributed to the incompatibility of the drug with EC.